Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Acute Lymphoblastic Leukaemia

Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission – long-term follow-up

Abstract

From 1984 to 1996, 31 consecutive children without sibling donors, aged 5–19 years (median 8) with acute lymphoblastic leukaemia (ALL) in second complete remission (CR), received unpurged autologous bone marrow transplantation (ABMT) after melphalan and single fraction total body irradiation (TBI). ABMT was performed using fresh unmanipulated marrow harvested after standard reinduction and consolidation therapy 2–11 months (median 5) after relapse. With a median survival of 2.9 years the probability of survival for all patients in continuing second CR was 45.1% (95% CI, 24%-62%) after 5 years. Regimen-related and non-leukaemia mortality was 7% (95% CI, 2%-26%). The longest time to second relapse from ABMT was 3.1 years. Pituitary and gonadal dysfunction requiring hormonal replacement therapy occurred in the majority of long-term survivors. Twelve patients developed cataracts. ABMT with melphalan/single fraction TBI has proved an effective anti-leukaemia treatment with low regimen-related mortality but significant long-term morbidity. The current approach of allogeneic BMT from an unrelated donor when no sibling donor is available, following conditioning with cyclophosphamide/ fractionated TBI has resulted in a reduced relapse rate and improved short-term overall survival in the treatment of relapsed childhood ALL. However, long-term results are awaited. Bone Marrow Transplantation (2000) 25, 599–603.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Rivera GK, Pinkel D, Simon JV et al. Treatment of acute lymphoblastic leukaemia. 30 years’ experience at St Jude Children's Research Hospital New Engl J Med 1993 329: 1289–1295

    Article  CAS  Google Scholar 

  2. Chessells JM . Treatment of childhood acute lymphoblastic leukaemia: present issues and future prospects Blood Rev 1992 6: 193–203

    Article  CAS  Google Scholar 

  3. Wheeler K, Richards S, Bailey C et al. Comparison of bone marrow transplantation and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience Br J Haematol 1998 101: 94–103

    Article  CAS  Google Scholar 

  4. Gaynon PS, Qu RP, Chappell RJ et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse: the Children's Cancer Group experience Cancer 1998 82: 1387–1395

    Article  CAS  Google Scholar 

  5. Dopfer R, Henze G, Bender-Gotze C et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission after intensive primary and relapse therapy according to BFM and coALL protocols: results of the German Co-operative Society Blood 1991 78: 2780–2784

    CAS  PubMed  Google Scholar 

  6. Uderzo C, Valsechi MG, Bacigalupo A et al. Treatment of childhood acute lymphoblastic leukaemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-years’ experience of the Italian Pediatric Hematology Oncology Association J Clin Oncol 1995 13: 352–358

    Article  CAS  Google Scholar 

  7. Barrett AJ, Horowitz MM, Pollock B et al. Bone marrow transplantation from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in second remission New Engl J Med 1994 331: 1253–1258

    Article  CAS  Google Scholar 

  8. Borgmann A, Schmid H, Hartmann R et al. Autologous bone marrow transplant compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis Lancet 1995 346: 873–876

    Article  CAS  Google Scholar 

  9. Parsons SK, Castellino SM, Lehmann LE et al. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic transplantation in selected children Bone Marrow Transplant 1996 17: 763–768

    CAS  PubMed  Google Scholar 

  10. Kersey JH, Weisdorf D, Nesbit ME et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high risk refractory acute lymphoblastic leukaemia New Engl J Med 1987 20: 461–467

    Article  Google Scholar 

  11. Billet AL, Kornmehl E, Tarbell NJ et al. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukaemia Blood 1993 81: 1651–1657

    Google Scholar 

  12. Helenglass G, Powles RL, McElwain TJ et al. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloid leukaemia in first remission Bone Marrow Transplant 1988 3: 21–29

    CAS  PubMed  Google Scholar 

  13. Carey P, Proctor SJ, Taylor P et al. Autologous bone marrow transplantation for high grade lymphoid malignancy using melphalan irradiation conditioning without marrow purging or cryopreservation Blood 1991 77: 1593–1598

    CAS  PubMed  Google Scholar 

  14. Schroeder H, Pinkerton CR, Powles RL et al. High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse Bone Marrow Transplant 1991 7: 11–15

    CAS  PubMed  Google Scholar 

  15. Eden OB, Lilleyman JS, Richards S et al. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII: report to the Medical Research Medical Council on behalf of the Working Party on Leukaemia in Childhood Br J Haematol 1991 76: 187–196

    Article  Google Scholar 

  16. Chessells JM, Bailey C, Richards S . Intensification of treatment and survival in all children with lymphoblastic leukaemia Lancet 1995 345: 143–148

    Article  CAS  Google Scholar 

  17. Chessells JM, Bailey C, Wheeler K et al. Bone marrow transplantation for high risk childhood acute lymphoblastic leukaemia in first remission: experience in MRC UKALL-X Lancet 1992 340: 565–568

    Article  CAS  Google Scholar 

  18. Sallan SE, Niemeyer CM, Billet AL et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia J Clin Oncol 1989 7: 1594–1601

    Article  CAS  Google Scholar 

  19. Weisdorf DJ, Billet AL, Hannan P et al. Autologous versus unrelated donor allogeneic marrow transplantation for ALL Blood 1997 90: 2962–2968

    CAS  PubMed  Google Scholar 

  20. Messina C, Cesaro S, Rondelli R . Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy Bone Marrow Transplant 1998 21: 1015–1021

    Article  CAS  Google Scholar 

  21. Messina C, Sotti G, Loiacona G et al. Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukaemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato Oncologia Pediatrica Bone Marrow Transplant 1998 21: 9–14

    Article  CAS  Google Scholar 

  22. Sutton L, Kuentz M, Cordonnier C et al. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukaemia in first complete remission. Factors predictive of transplant related mortality and influence of total body irradiation modalities Bone Marrow Transplant 1993 12: 583–589

    CAS  PubMed  Google Scholar 

  23. Morgan TL, Falk PM, Kogut N et al. A comparison of single dose and fractionated total body irradiation on the development of pneumonitis following bone marrow transplantation Int J Radiat Oncol Biol Phys 1996 36: 61–66

    Article  CAS  Google Scholar 

  24. Belkacemi Y, Pene F, Touboul E et al. Total body irradiation before bone marrow transplantation for acute leukaemia in first or second complete remission: results and prognostic factors in 326 consecutive patients Strahlenther-Onkol 1998 174: 92–104

    Article  CAS  Google Scholar 

  25. Thomas BC, Stanhope R, Plowman PN, Leiper AD . Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood Acta Endocrinol Copenh 1993 128: 508–512

    Article  CAS  Google Scholar 

  26. Ogilvy- Stuart AL, Clark DJ, Wallace WHB et al. Endocrine deficit after fractionated total body irradiation Arch Dis Child 1992 67: 1107–1110

    Article  CAS  Google Scholar 

  27. Hongeng S, Krance RA, Bowman LC et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia Lancet 1997 350: 767–771

    Article  CAS  Google Scholar 

  28. Oakhill A, Pamphilon DH, Porter MN et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission Br J Haematol 1996 94: 574–578

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaidya, S., Atra, A., Bahl, S. et al. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission – long-term follow-up. Bone Marrow Transplant 25, 599–603 (2000). https://doi.org/10.1038/sj.bmt.1702214

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702214

Keywords

This article is cited by

Search

Quick links